Home/Filings/4/0001127602-21-012695
4//SEC Filing

Boratto Eva C 4

Accession 0001127602-21-012695

CIK 0000064803other

Filed

Apr 1, 8:00 PM ET

Accepted

Apr 2, 5:00 PM ET

Size

19.4 KB

Accession

0001127602-21-012695

Insider Transaction Report

Form 4
Period: 2021-02-01
Boratto Eva C
SVP, Cont & Chief Acct Officer
Transactions
  • Award

    Common Stock

    2021-02-01+88,500159,582.045 total
  • Tax Payment

    Common Stock

    2021-04-01$74.30/sh40,128$2,981,510119,454.045 total
  • Award

    Stock Option

    2021-04-01$74.30/sh+103,663$7,702,161103,663 total
    Exercise: $74.30From: 2022-04-01Exp: 2031-04-01Common Stock (103,663 underlying)
  • Tax Payment

    Common Stock

    2021-04-01$74.30/sh649$48,221120,236.045 total
Holdings
  • Stock Option

    Exercise: $104.82From: 2017-04-01Exp: 2023-04-01Common Stock (21,509 underlying)
    21,509
  • Stock Option

    Exercise: $58.34From: 2021-04-01Exp: 2030-04-01Common Stock (168,956 underlying)
    168,956
  • Stock Option

    Exercise: $78.05From: 2018-04-03Exp: 2024-04-03Common Stock (35,062 underlying)
    35,062
  • Stock Option

    Exercise: $62.21From: 2019-04-01Exp: 2025-04-01Common Stock (35,030 underlying)
    35,030
  • Stock Option

    Exercise: $54.19From: 2020-04-01Exp: 2029-04-01Common Stock (202,007 underlying)
    202,007
  • Common Stock (restricted)

    2,242
  • Stock Option

    Exercise: $102.26From: 2016-04-01Exp: 2022-04-01Common Stock (27,392 underlying)
    27,392
Footnotes (11)
  • [F1]Represents shares earned by the reporting person pursuant to certain performance stock units (the "PSUs"), which were granted to the reporting person under the Issuer's 2017 Incentive Compensation Plan on February 1, 2021. The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 1, 2021. The PSUs vested and settled on April 1, 2021.
  • [F10]The number of shares subject to the option were calculated using a 30-day average price.
  • [F11]Options became exercisable in four equal annual installments, commencing 4/1/2021.
  • [F2]Surrender of shares in payment of taxes due upon the vesting and settlement of the PSUs on April 1, 2021.
  • [F3]Surrender of shares in payment of taxes due upon the vesting and settlement of a restricted stock unit award on April 1, 2021.
  • [F4]Option becomes exercisable in four equal annual installments, commencing 4/1/2022.
  • [F5]Option became exercisable in four equal annual installments, commencing 4/1/2016.
  • [F6]Option becomes exercisable in four equal annual installments, commencing 4/1/2017.
  • [F7]Option became exercisable in four equal annual installments, commencing 4/3/2018.
  • [F8]Option became exercisable in four equal annual installments, commencing 4/1/2019.
  • [F9]Option became exercisable in four equal annual installments, commencing 4/1/2020.

Issuer

CVS HEALTH Corp

CIK 0000064803

Entity typeother

Related Parties

1
  • filerCIK 0001580827

Filing Metadata

Form type
4
Filed
Apr 1, 8:00 PM ET
Accepted
Apr 2, 5:00 PM ET
Size
19.4 KB